Discontinuation report CEFZIL POWDER FOR ORAL SUSPENSION-250 MG/ 5 ML

Last updated on 2017-08-25 History
Report ID 1685
Drug Identification Number 02163683
Brand name CEFZIL POWDER FOR ORAL SUSPENSION-250MG/5ML
Common or Proper name Cefprozil
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status CANCELLED POST MARKET
Active Ingredient(s) CEFPROZIL
Strength(s) 250mg
Dosage form(s) Powder for solution
Route of administration oral
Packaging size 1 BTL x 100ml
ATC code J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2017-08-31
Actual discontinuation date 2017-08-23
Remaining supply date 2017-08-23
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply 125mg/5ml 75ml and 100ml will be available until the end of Dec. 2017.
Company comments
Health Canada comments
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
MONTRÉAL (ST-LAURENT), QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2017-08-25 French Compare
v11 2017-08-25 English Compare
v10 2017-07-29 French Compare
v9 2017-07-29 English Compare
v8 2017-06-19 French Compare
v7 2017-06-19 English Compare
v6 2017-06-02 French Compare
v5 2017-06-02 English Compare
v4 2017-04-03 French Compare
v3 2017-04-03 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare